Chemotherapy After Hormone Therapy Fails Leaves Metastatic Breast Cancer Patients With Grim Odds
A study of more than 5,000 US patients with HR-positive/HER2-negative metastatic breast cancer found median survival of only 13.5 months ...
Tag: oncology
Cancer Patients Follow Four Distinct Paths When Seeking Information, Study Finds
A survey of 205 Israeli cancer patients identified four distinct information-seeking archetypes, with religiosity the strongest differentiator and generative AI ...
Targeting the Ubiquitin Machinery to Rewire KRAS-Driven Cancers
A new review argues that deubiquitinase enzymes within the ubiquitin-proteasome system offer promising therapeutic angles against KRAS-driven cancers that resist ...
Decision-Curve Analysis Is a Bridge, Not an Endpoint, for Clinical AI in Oncology
Researchers argue that a widely used statistical measure of clinical utility must sit within a staged evidence pathway before cancer ...
Liposomal Paclitaxel With HER-2 Blockers Shows Strong Real-World Results in Advanced Breast Cancer
A real-world study of 526 patients found that paclitaxel liposome combined with anti-HER-2 targeted therapies delivered median overall survival of ...
Liquid Droplets Inside Cancer Cells Explain Why a Leukemia Drug Works So Slowly
A new Cell Research study shows that BCR-ABL1 forms liquid-like phase-separated condensates inside leukemic cells that physically slow tyrosine kinase ...
Early Palliative Care Boosts Quality of Life and May Extend Survival in Cancer Patients
A meta-analysis of 39 randomized controlled trials involving 8,399 cancer patients found that early palliative care significantly improves quality of ...
China’s Cancer Research Shifts From Molecular Reductionism to Holistic Integrative Medicine
A new review maps how Chinese cancer research has evolved from single-target molecular reductionism toward a three-tier holistic integrative medicine ...
HER2-Low Breast Cancer Mirrors HER2-0 in Metastasis Timing but Confers a Survival Edge
A retrospective study of nearly 1,600 patients finds that HER2-low breast cancer behaves like HER2-0 disease in metastatic timing and ...
Pan-RAS Inhibitor Daraxonrasib Delivers Landmark Survival Gains in Pancreatic Cancer
Two landmark New England Journal of Medicine studies show the pan-RAS inhibitor daraxonrasib nearly doubles survival in previously treated metastatic ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!